The increased analytical resolution and growing understanding of the transcriptome opens opportunities for scientific discovery and business development. At Nebion, we strive to be best-in-class for LEARNING FROM THE TRANSCRIPTOME using advanced data analytics and AI.
As an Immunai company, Nebion aims at being a place where people share their enthusiasm, their knowledge and their vision. In short: a place where we all find purpose in what we do, fulfillment in how we do it, and happiness with who we do it.
The cell type specific transcriptome provides unique insights into how our cells work, how they drive growth, respond to disease, and restore health. As part of Immunai, we share its bold vision of discovering novel therapeutic targets and approaches.